...
首页> 外文期刊>British journal of ophthalmology >Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis.
【24h】

Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis.

机译:粘多糖贮积症患者的眼科特征的诊断和管理。

获取原文
获取原文并翻译 | 示例
           

摘要

Ocular pathology is common in patients with mucopolysaccharidosis (MPS), a hereditary lysosomal storage disorder, where the eye as well as other tissues accumulate excessive amounts of glycosaminoglycans. Despite genetic and phenotypic heterogeneity within and between different types of MPS, the disease symptoms and clinical signs often manifest during the first 6 months of life with increasing head size, recurrent infections, umbilical hernia, growth retardation and skeletal problems. Typical ocular features include corneal clouding, ocular hypertension/glaucoma, retinal degeneration and optic nerve atrophy. Visual deterioration and sensitivity to light may substantially reduce the quality of life in MPS patients, particularly when left untreated. As an early intervention, haematopoietic stem cell transplantation and/or enzyme replacement therapy are likely to improve patients' symptoms and survival, as well as visual outcome. Thus, it is of utmost importance to ensure proper detection and accurate diagnosis of MPS at an early age. It is of fundamental value to increase awareness and knowledge among ophthalmologists of the ocular problems affecting MPS patients and to highlight potential diagnostic pitfalls and difficulties in patient care. This review provides insight into the prevalence and severity of ocular features in patients with MPS and gives guidance for early diagnosis and follow-up of MPS patients. MPS poses therapeutic challenges in ocular management, which places ophthalmologists next to paediatricians at the forefront of interventions to prevent long-term sequelae of this rare but serious disease.
机译:眼黏膜多糖症(MPS)是一种遗传性溶酶体贮积病,其眼睛和其他组织中会积累过量的糖胺聚糖,因此眼部病理很常见。尽管在不同类型的MPS内和之间存在遗传和表型异质性,但疾病症状和临床体征通常在生命的头6个月内表现出来,头部大小增加,反复感染,脐疝,生长迟缓和骨骼问题。典型的眼部特征包括角膜混浊,高眼压/青光眼,视网膜变性和视神经萎缩。视觉恶化和对光的敏感性可能会大大降低MPS患者的生活质量,尤其是未经治疗时。作为早期干预措施,造血干细胞移植和/或酶替代疗法可能会改善患者的症状,生存率以及视觉效果。因此,最重要的是确保在早期就正确检测和准确诊断MPS。提高眼科医生对影响MPS患者的眼部疾病的认识和知识,并强调潜在的诊断缺陷和患者护理困难,具有根本价值。这篇综述提供了对MPS患者眼部疾病患病率和严重性的见解,并为MPS患者的早期诊断和随访提供指导。 MPS在眼科治疗方面提出治疗挑战,使眼科医生在儿科医师旁边处于干预的最前沿,以预防这种罕见但严重的疾病的长期后遗症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号